How to Use Cologuard: From Mailbox to Lab in Under 24 Hours

Who Cologuard Is For

Cologuard is approved for average-risk adults age 45 and older, and major U.S. guidelines now list it alongside colonoscopy and FIT as one of several acceptable screening options. Average-risk means you don't have a personal history of colorectal cancer, advanced polyps, or inflammatory bowel disease, and no strong family history or genetic syndrome like Lynch.

If any of those apply to you, Cologuard is not the right test. People at higher risk need colonoscopy on a tighter schedule because the screening question is no longer "is something here?" but "what's growing right now and how fast?" Stool tests can answer the first; only colonoscopy can answer the second.

For everyone else, the recommended interval is every three years per the American Cancer Society, and every one to three years per the U.S. Preventive Services Task Force. The upper limit is age 75 for routine screening, with shared decision-making between 76 and 85.

The Kit and What's Inside

The kit arrives in a corrugated box about the size of a small microwave. Inside you'll find:

• A plastic collection bucket that fits over your toilet bowl
• A separate sample tube with a swab attached to the lid
• A bottle of preservative liquid
• A return shipping label and a sealed plastic bag for the packed kit

Your physician orders the test and the kit ships directly to your address. There is no lab visit, no blood draw, and no diet or medication change in the days before.

Step by Step: Collecting and Shipping

The collection itself is one bowel movement. Pick a day when you're at home, ideally with a FedEx pickup or drop-off available the next day so the sample doesn't sit.

1. Place the bucket. Lift the toilet seat, set the white collection bucket on the rim, and lower the seat back down to hold it in place. 2. Use the toilet normally. The bucket catches stool. Don't urinate into the bucket; toilet paper goes in the trash, not the bucket. 3. Take the small swab sample. Open the small tube. Brush the attached probe across the surface of the stool a few times, then close it. This portion goes to the lab as the FIT (fecal immunochemical test) component. 4. Pour in the preservative. Open the larger preservative bottle and pour the entire contents into the bucket on top of the stool. The liquid stabilizes DNA so it survives shipping at room temperature. 5. Seal everything. Snap the bucket lid on, place the bucket and the smaller swab tube in the included plastic bag, and put the bag back in the original box. 6. Ship within 24 hours. Apply the prepaid label and drop the box at FedEx the same day or the next morning. The kit's stability window is measured in days, not weeks, so the sooner it ships, the better the sample.

If the kit sits longer than the stability window, the lab may reject it and ask you to redo the collection. The most common reason for a rejected sample is a delay between collection and shipping, which is why scheduling the collection around a known pickup time matters.

What the Lab Looks For

Cologuard combines two technologies in one kit. The swab portion is a fecal immunochemical test that detects human hemoglobin, the same protein measured by standalone FIT. The bucket portion goes through DNA extraction. The lab runs assays for KRAS gene mutations, methylation patterns on the NDRG4 and BMP3 genes, and a reference marker, all of which appear at higher frequencies in cells shed from colorectal tumors and advanced polyps.

The result is a single positive or negative, generated by an algorithm that combines the DNA findings with the hemoglobin reading. Results typically come back to your physician within two weeks.

What Your Result Means

A negative result means the lab found neither suspicious DNA changes nor blood at the threshold for concern. Cologuard's specificity in the original DeeP-C trial of 9,989 patients was about 87%, and the next-generation version raised that to roughly 91%. That means roughly 9 to 13 in every 100 people with a normal colon will get a false positive.

A positive result is not a cancer diagnosis. In post-market data, roughly two-thirds of patients with a positive Cologuard turn out to have some form of colorectal neoplasia at follow-up colonoscopy, and about 1 in 3 of those will have advanced disease. Most positives reveal polyps rather than cancer, which is why the diagnostic colonoscopy is the part of the process that delivers the actual answer.

The action after a positive is the same regardless: a diagnostic colonoscopy. This is non-negotiable, because the test's value depends on the follow-up.

A positive Cologuard followed by no colonoscopy gives you the worst of both worlds, the anxiety of an abnormal result without the answer that resolves it. Patients who do follow up with colonoscopy after a positive find clinically meaningful disease at high enough rates that the workup is worth the trouble.

After a negative colonoscopy following a positive Cologuard, you're not on a special surveillance pathway. The colonoscopy resets the clock, and standard screening intervals apply going forward.

Cologuard Compared to Other Screening Choices

Cologuard's case rests on convenience and high cancer sensitivity, both at a cost in specificity. The next-generation version of the test, evaluated in the 20,176-patient BLUE-C trial, caught 93.9% of cancers and 43.4% of advanced precancerous lesions, compared to 67.3% and 23.3% for FIT. Specificity went the other direction: 90.6% for the new Cologuard versus 94.8% for FIT, meaning Cologuard generates more false positives.

There is no single right answer here. Colonoscopy is the most thorough test and the only one that removes polyps in the same session, but it requires bowel prep, sedation, and a procedural appointment. FIT is cheaper and more specific, but it misses more cancers and many more precancerous lesions.

Cologuard sits in between, with the highest sensitivity of any non-invasive option and the longest interval among stool tests. The screening literature has a useful aphorism: the best test is the one that gets done.

Where Cologuard Fits in Your Screening Plan

If you're an average-risk adult between 45 and 75, Cologuard is a reasonable first step, especially if a colonoscopy schedule keeps slipping or your insurance hasn't worked out the prep coverage. The mailroom-to-mailroom workflow removes the most common reasons people put off screening, and the cancer sensitivity is high enough that a negative result genuinely lowers your three-year risk.

Instalab's Cologuard test ($599) covers the kit, the lab analysis, and the physician order required to ship it to your home. A positive result means scheduling a colonoscopy; a negative result means setting a calendar reminder for three years out. Either way, the test only counts if you complete the loop.